Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: We hereby report on the immunomodulatory effects induced over time in patients with advanced relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) and B-lineage acute lymphoblastic leukemia (B-ALL) treated with the commercial CAR-T-cell product tisagenlecleucel. We obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Guarini, Anna, Radice, Giulia, Peragine, Nadia, Buracchi, Chiara, De Propris, Maria Stefania, Di Rocco, Alice, Di Rocco, Arianna, Chiaretti, Sabina, Moretti, Alex, Napolitano, Sara, Martelli, Maurizio, Balduzzi, Adriana, Gaipa, Giuseppe, Biondi, Andrea, Foà, Robin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177375/
https://www.ncbi.nlm.nih.gov/pubmed/37173879
http://dx.doi.org/10.3390/cancers15092411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177375/
https://www.ncbi.nlm.nih.gov/pubmed/37173879
http://dx.doi.org/10.3390/cancers15092411

Ejemplares similares